Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-097491

Interim CEO & General Counsel gave up 24,339 shares (to pay taxes)

  • Interim CEO & General Counsel acquired 57,292 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Vogt Frederick G · Interim CEO & General Counsel

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-03 Exercise or conversion : show line 1 in the form +10,417 169,726 D
2024-09-03 Shares withheld for taxes : show line 2 in the form −4,426 $10.85 $48,022 165,300 D
2024-09-03 Exercise or conversion : show line 3 in the form +46,875 212,175 D
2024-09-03 Shares withheld for taxes : show line 4 in the form −19,913 $10.85 $216,056 192,262 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-09-03 Exercise or conversion : show line 5 in the form Restricted Stock Units −10,417 62,504 D
2024-09-03 Exercise or conversion : show line 6 in the form Restricted Stock Units −46,875 46,875 D
Loading xslF345X05/tm2423453-4_4seq1.xml…